- Related Products
MedEx answers any queries you might have regarding Baraclude 1mg purchase, shipping and payment terms.
Feel free to contact support through inquiry form, MedeEx is fully dedicated towards your needs 24/7.
Hepatitis B virus usually results in hepatitis B infection. This kind of virus can spread through sexual contact, blood, or during childbirth. Hepatitis B infection in acute stage leads to the icterus (yellowing of the skin) or liver inflammation, while at the chronic stage it may trigger cirrhosis or hepatic cancer. About 1/10 of patients suffer from chronic hepatitis B infection, which may lead to the end-stage liver disease (ESLD) and hepatocellular carcinoma (HCC).
Baraclude 1 mg is intended for the treatment of chronic hepatitis B virus infection in patients of 16 years or older suffering from active liver failure.
The common dose for adult people and teens over the age of 16 is 0.5 mg once a day. People who have experienced active disorder while using a similar drug (lamivudine) should increase th dose to 1 mg once a day. Patients with kidney failure may need a lower dose.
The drug Baraclude 1 mg is intended for oral intake. Take a pill once a day about two hours after eating. If you’re using Baraclude 1 mg oral solution, carefully measure the dosage with a special spoon. Avoid using a household spoon, as you may take a wrong dose.
Baraclude falls within the group of drugs called antivirals. It is intended for the treatment of chronic hepatitis B infection. It acts by preventing the hepatitis B virus from replication. Hepatitis B infection can’t be cured completely. Entecavir can reduce the amount of virus in the organism and decrease the liver injury caused by HBV.
Patients who have allergy to Baraclude or any of its components shouldn’t use this drug. Signs of a severe allergic response usually include; shivering, heat, increased heart rate, wheezing or coughing, breathing problems, vertigo, hot flushes, perspiration and face swelling.
Severe acute exacerbations of hepatitis B have been reported in people who have stopped anti-hepatitis B treatment, including Baraclude. Liver function should be monitored carefully for about a few months in patients who stop the treatment with Baraclude 1 mg. If necessary, they should start anti-hepatitis B treatment.